Loading Filters
Showing 1–3 of 3 results
-
Comments & Opinion |
Certolizumab pegol
- Gil. Y. Melmed and Stephan R. Targan are at the Cedars-Sinai...
-
Reviews |
Future biologic targets for IBD: potentials and pitfalls
- Stephan R. Targan is Director of both the...
-
News & Views |
Steroid-refractory ulcerative colitis—ciclosporin or infliximab?
- Stephan R. Targan is Director of both the...